We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cvs Group Plc | LSE:CVSG | London | Ordinary Share | GB00B2863827 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-44.00 | -4.32% | 975.00 | 976.00 | 984.50 | 1,040.00 | 980.00 | 1,040.00 | 488,057 | 16:35:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Veterinary Svcs-animal Specs | 608.3M | 41.9M | 0.5843 | 16.81 | 704.58M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/9/2015 12:58 | I will be adding further on any tangible dip, a pause for breath is to be expected. | lomax99 | |
23/9/2015 10:29 | gargleblaster, Thanks, that sounds about right. I am invested in CVSG. Eno | eno nedlog | |
22/9/2015 21:20 | eno - I think it is a case of a company having tremendous growth but bumping against a full valuation (22.2X fwd earnings) - hence the period of consolidation. If you have the patience you should be rewarded imv, but dyor etc. | gargleblaster | |
22/9/2015 12:44 | Is this sideways move of the share price due to its overeaching itself in March April and June? Or just pacing with the rest of the market? Eno | eno nedlog | |
28/8/2015 10:59 | Does anyone have any info on this share?TIA | lollipop3 | |
29/7/2015 12:08 | Support around the 600p mark? | mrmediumterminvestor | |
27/7/2015 09:48 | Investorschamp - takeover - by who?? Pets at Home already have a massive debt millstone around their neck. Who are the other candidates?? Glib comment imv. | gargleblaster | |
27/7/2015 08:22 | Sound TU imv. In line, and like for like's up 6.8%. Market seems okay with that. Am happy to hold long term! | gargleblaster | |
23/7/2015 19:11 | Looking to add a few more....... | lomax99 | |
23/7/2015 15:00 | Seems to be falling from grace, no news making shareholders bored, will wait and watch alittle longer as I hope its bottomed out | farmsted | |
03/6/2015 17:21 | Indeed indeed. | mike740 | |
03/6/2015 16:35 | Seems to be making a habit of "the late charge"! | gargleblaster | |
03/6/2015 16:21 | CVSG Lovely strong finish today. The next leg up truely well on its way. | mike740 | |
03/6/2015 08:08 | CVSG: interesting to note one brokers share price TARGET........ 07 May Berenberg Buy 663.50 560.00 730.00 Reiterates 730p. | mike740 | |
02/6/2015 20:35 | CVSG looks rather dear until you take into account that EPS growth here is at a cracking rate. If investors bought while P/E was 50 plus why shouldnt they Buy whilst P/E is at forecasts of half of that. People spend a lot of money on there Pets. CVS Group PLC FORECASTS 2015 2016 Date Rec Pre-tax (£) EPS (p) DPS (p) Pre-tax (£) EPS (p) DPS (p) N+1 Singer 01-06-15 CORP 17.60 22.80 3.00 19.73 25.50 4.00 Peel Hunt LLP 29-05-15 BUY 18.83 25.52 3.00 20.62 27.62 3.50 Investec Securities 09-04-15 BUY 17.90 23.63 2.88 20.20 26.50 3.16 2015 2016 Pre-tax (£) EPS (p) DPS (p) Pre-tax (£) EPS (p) DPS (p) Consensus 17.90 23.63 3.00 20.20 26.50 3.50 1 Month Change 0.15 0.00 0.00 0.00 0.00 0.00 3 Month Change 1.18 2.10 0.00 1.70 2.58 0.00 GROWTH 2014 (A) 2015 (E) 2016 (E) Norm. EPS 18.69% 172.49% 12.16% DPS 33.33% 50.00% 16.67% INVESTMENT RATIOS 2014 (A) 2015 (E) 2016 (E) EBITDA £18.30m £22.63m £25.48m EBIT £8.20m £m £m Dividend Yield 0.31% 0.46% 0.54% Dividend Cover 4.34x 7.88x 7.57x PER 75.42x 27.68x 24.68x PEG 4.04f 0.16f 2.03f Net Asset Value PS -47.38p 61.80p 75.10p | mike740 | |
02/6/2015 15:25 | CVSG veterinary services, on the verge of a breakout and next leg up. Looks dear but EPS Increase next year with bolt ons. | mike740 | |
23/5/2015 19:03 | Lomax99 Big Thankyou for your post and well done here.CVS took on a huge debt to buy up these vets over the last 7 years and the market held the companies share price down as a result.As the debt has reduced and profits have gone up so has the share price.PVG looks to have had a cash shortage from day one and thus could not buy up other vets in any kind of numbers.You are also spot on with your view that the big two are going to keep on buying and expanding.CVS has seen its stock rise 200% over 7 years with rocket under the price over the last two.We will have to wait and see what PVG does but without the odd £100M plus being raised they don't have a chance in hell of buying up vets in the UK.A much safer and cheaper option would be to grow the pet plans and buying side of the group in quick order.PVG have just hired a director and talked about a global company. Have you any idea where UK vets sit in the world rankings.? In other words is the UK ahead or to the rear of other nations product / price and so on. Thanks from the hound and myself. | pet lover | |
23/5/2015 10:43 | Pet lover. I will watch PVG with interest and may make an investment, interestingly I see from the prospectus that Gervais William's Miton group has a holding. I have been in CVS a long time, what attracted me was a large fragmented market ripe for consolidation, buying small practices on low PE multiples (with little alternative exit routes) and, efficiently, consolidating. CVS was originally VC funded, and aimed to employ more professional management once the industry was de-regulated, opening the prospect for non-vets to own & operate vets practices. CVS's regimented acquisitive growth has enabled it to reap economies of scale through efficiently managing the process, thereby transforming the underlying EBITDA performance of practices acquired, something they themselves could not hope to do. Pet Health plans, specialist laboratory services, online pharmacies, etc are all a logical extension to build brand loyalty and to seek/prevent leakage of extra margin. I can see the network opportunity that PVG may have to target a generic pet health plan to the other 75% of the market, it will be interesting to see how it develops as I suspect the two lead consolidators will be looking to significantly increase their combined 25% share in the next few years - although there is probably plenty of scope for all to grow. I note reference in the PVG prospectus that their 15 practices had been an attempt by the previous management to act as a consolidator, it implies they had been largely unsuccessful at that - perhaps the new management will make a better fist of it, presumably however the main idea to focus on generic pet health plans for third party practices? | lomax99 | |
22/5/2015 21:13 | The pet plans make large profits and open the door to cross sell other product.The hound and I are on the look out for any company that can grow these plans at the kind of rates that CVS is doing right now. Denplan is another in the field. CVS can only sell those plans through its own vets so the total numbers of plans to be sold has a ceiling.I am not saying the pet plan growth here will slow any time soon just that their is a limit. CVS is also growing profits in various other areas as you rightly say. PVG has got a different model selling pet health plans on behalf of other independent vets C 75% of the total market.PVG also has a buying group doing the same.To sum up if PVG can get 1,000 Vets selling its health plans over time it could take the cream of profits and margin without the massive costs of buying and running vets.Long term investors here ran the risk of very high debt in the early years but at the end of the day that proved the very time to invest. PVG is unknown it's even listed on the big board not on Aim. The hound and I want to mimic the returns here over the last few years. I would also like Mr Slater to take a look if he reads this.From the hound and myself night night. | pet lover | |
22/5/2015 20:33 | The real attraction of this business is the cash generation and the ability to sell a growing number of ancillary services to customers as the number of core practices grows. While operating profit increased to £5.8m (2013: £3.8m) cash generated from operations was £12.9m (2013: £10.5m) and free cash generation £8.4m. At the half year, the Practice Division operated 276 veterinary surgeries across the UK under a number of well-established local brands, primarily focused on the small animal market. Management estimates that CVS has an 11% share of the UK small animal veterinary market. The Group employed almost 3,000 people at the half year end The £4.1m paid for acquisitions historically reflected EBITDA of approximately £1.1m, an attractive multiple. Their Healthy Pet Club schemes have grown significantly with membership at 31 December 2014 in excess of 192,000 pets, an increase of almost 39% since December 2013. Income from Healthy Pet Club schemes represented 12.5% of the income of the Practice Division for the six month period up from 10.5% in the comparable period. The schemes offer discounted products and services aiming to improve clinical compliance levels amongst members and to protect practice sales by bonding pet owners to their local CVS surgery. Clearly as more practices are acquired there is a big opportunity to plug more clients into this. lomax99. Thankyou for your views I can agree in part but CVS Only made £5.8M from all those vets in 6 months.Profits for the company on the other hand went up by a very large amount as did the quality of those earnings. Those pet health plans added a full 2% points to the practice division. Profits have been going up in line with the rapid sale and take up of these health plans over the last few years.It can be seen that it's the add on's that are where the real growth is comming from. | pet lover | |
22/5/2015 18:50 | I don't see the health pet plans being key to CVS TBH, they will however help build brand loyalty/aid retention. The key element to the CVS story is acting as an efficient consolidator in a highly fragmented market, with comparatively modest exit opportunities for retiring practice owners. Witness the modest acquisition highlighted in CVS's interims - they paid only £4.1M to obtain c. £1.1M of Ebitda(!), and that is before they streamline anything achieving economies of scale for procurement, central admin, etc, etc. The exciting thing is that the two lead consolidators still only account for c 25% of the market, so there is a very healthy pipeline indeed for future acquisitive growth. | lomax99 | |
22/5/2015 08:21 | I was wrong in thinking this share was overvalued one just has to look at the chart. The hound and I have done our research on these and the other two listed vets. Again I thought PETS was overvalued at its float price but has since done very well. The hound and I have gone for PVG as yet an unknown stock that came to the market through an rto in the spring. CVS is now a very large company with good management and I can see the stock hitting ten pounds within 3 to 4 years.If the truth be known I think the driving force for the profits here is due in part to the rise in its health pet plans. It's those plans that I have an idea will be the key at PVG as well.The sector as a whole is well liked for its stable cashflow. | pet lover |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions